Staffan Wahlin

Staffan Wahlin is a Senior Lecturer affiliated with the Department of Medicine at Karolinska Institutet, Huddinge. He leads the Stål and Wahlin research group, focusing on metabolic and inflammatory liver diseases, including hepatocellular carcinoma, porphyria, non-alcoholic fatty liver disease (NAFLD), autoimmune hepatitis, and primary biliary cholangitis. His work integrates clinical and translational research to develop biomarkers and treatment strategies for liver diseases.

Key collaborations include SweHep (national study group), SciLifeLab, and international networks. His research projects include biomarker development for HCC, macrophage roles in NASH fibrosis, and hemostasis in liver cirrhosis. Funding sources include the Swedish Cancer Society, European Research Council, and Region Stockholm.

Wahlin has advised PhD student Sanna Norén and contributed to over 60 peer-reviewed articles. His labs focus on liver tissue biobanking, advanced diagnostic methods, and prospective clinical trials. He also explores the long-term outcomes of liver transplantation and genetic liver disorders like porphyrias.